Page last updated: 2024-09-03

r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid and Influenza, Human

r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid has been researched along with Influenza, Human in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Carr, J; Herbert, J; Hutchinson, WL; Ives, J; Jakob-Roetne, R; Pepys, MB; Suzuki, M; Yamamura, K1

Other Studies

1 other study(ies) available for r-1-(6-(r-2-carboxypyrrolidin-1-yl)-6-oxohexanoyl)pyrrolidine-2-carboxylic acid and Influenza, Human

ArticleYear
Influenza virus infection is not affected by serum amyloid P component.
    Molecular medicine (Cambridge, Mass.), 2002, Volume: 8, Issue:1

    Topics: Animals; Antibodies, Viral; Carboxylic Acids; Hemagglutination, Viral; Humans; Influenza A virus; Influenza, Human; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Protein Binding; Pyrrolidines; Recombinant Fusion Proteins; Serum Amyloid P-Component; Species Specificity

2002